🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

382 results for “Ology” Clear

  1. [225Ac]Ac-AKY-1189 (therapeutic)

    Aktis Oncology

    Urothelial Carcinoma Bladder

    phase 1 small molecule active

    1 trial

  2. [225Ac]Ac-AKY-2519 (therapeutic)

    Aktis Oncology

    Castration Resistant Metastatic Prostate Cancer

    phase 1 small molecule active

    1 trial

  3. ateganosine

    MAIA Biotechnology

    Resectable Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  4. cannabis

    BRIGHT MINDS BIOSCIENCES INC.

    Behavioral Pharmacology of Cannabis

    phase 1 small molecule completed

    1 trial

  5. evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Higher Risk Myelodysplastic Syndromes

    phase 1 small molecule terminated

    1 trial

  6. evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Acute Myeloid Leukemia

    phase 1 small molecule terminated

    1 trial

  7. neratinib

    PUMA BIOTECHNOLOGY, INC.

    Healthy

    phase 1 small molecule completed

    5 trials

  8. neratinib

    PUMA BIOTECHNOLOGY, INC.

    Tumors

    phase 1 small molecule completed

    1 trial

  9. questionnaires

    Cardiff Oncology

    Anxiety

    phase 1 other active

    1 trial

  10. ziftomenib

    Kura Oncology

    Gastrointestinal Stromal Tumor (GIST)

    phase 1 small molecule active

    1 trial

  11. Atenolol

    Cardiff Oncology

    Marfan Syndrome

    approved small molecule completed

    1 trial

  12. BOTOX 200 UNITÉS ALLERGAN, poudre pour solution injectable, DYSPORT 500 UNITES SPEYWOOD, poudre pour solution injectable

    Ipsen

    Upper limb spasticity (ULS) of any aetiology (in US and France) or post- stroke ULS (in Canada)

    approved small molecule active

    1 trial

  13. Bimatoprost

    Cardiff Oncology

    Graves' Ophthalmopathy

    approved small molecule completed

    1 trial

  14. CARDIOPLEGIA SOLUTIONS

    The George Institute

    Cardiovascular pathology

    approved small molecule active

    1 trial

  15. Carvedilol

    Cardiff Oncology

    Cirrhosis, Liver

    approved small molecule active

    1 trial

  16. Carvedilol

    Cardiff Oncology

    Cirrhoses, Liver

    approved small molecule active

    1 trial

  17. Celestone Cronodose suspensión inyectable, Plasma rich in growth factors

    Wuhan Createrna Science and Technology Co., Ltd

    Low back pain

    approved small molecule active

    1 trial

  18. Folic Acid

    Cardiff Oncology

    Depression

    approved small molecule completed

    1 trial

  19. Hidrathea 9 mg/ml colirio en solución, Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución

    Wuhan Createrna Science and Technology Co., Ltd

    Dry Eye Disease

    approved small molecule active

    1 trial

  20. Invokana 100 mg film-coated tablets, Xigduo 5 mg/850 mg film-coated tablets, Vokanamet 150 mg/850 mg film-coated tablets, Forxiga 10 mg film-coated tablets, Vokanamet 50 mg/1,000 mg film-coated tablets, Invokana 300 mg film-coated tablets, Forxiga 5 mg film-coated tablets, Vokanamet 50 mg/850 mg film-coated tablets, Synjardy 12.5 mg/1,000 mg film-coated tablets, Synjardy 12.5 mg/850 mg film-coated tablets, Jardiance 25 mg film-coated tablets, Synjardy 5 mg/1,000 mg film-coated tablets, Xigduo 5 mg/1,000 mg

    Wuhan Createrna Science and Technology Co., Ltd

    Type 2 diabetes mellitus

    approved small molecule active

    1 trial

  21. Liraglutide

    Sana Biotechnology

    Morbid Obesity

    approved small molecule completed

    1 trial

  22. Pharmacokinetic based dosage change

    Cardiff Oncology

    Severe Haemophilia A

    approved small molecule completed

    1 trial

  23. Plasma rich in growth factors

    Wuhan Createrna Science and Technology Co., Ltd

    Foot ulcers in diabetic patients with peripheral arterial disease

    approved small molecule active

    1 trial

  24. Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución, Hidrathea 9 mg/ml colirio en solución

    Wuhan Createrna Science and Technology Co., Ltd

    Dry Eye Disease

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources